Skip to main content
. 2022 Jun 1;11(11):3145. doi: 10.3390/jcm11113145

Table 2.

Comparison of Characteristics of ENEV Group vs. EP Group.

ENEV EP OR 95% CI p Value
N 32 (46.38%) 37 (53.62%)
Demographic characteristics
Mean Age 71.84 65.6 0.82613–13.826 0.071 a
Male 16 (50%) 25 (67.57%) 0.485 0.161–1.418 0.216 b
Female 16 (50%) 12 (32.43%)
Etiology
Postsurgical 7 (21.88%) 19 (51.35%) 0.271 0.0783–0.848 0.023 c
Exogenous 18 (56.25%) 5 (13.51%) 7.946 2.273–33.135 0.0005 c
Endogenous 2 (6.25%) 7 (18.92%) 0.291 0.027–1.695 0.161 b
Post-traumatic 5 (15.63%) 5 (13.51%) 1.182 0.244–5.738 1 b
Past Medical History
Diabetes 19 (59.38%) 24 (64.86%) 0.794 0.267–2.352 0.836 b
Immunosuppressed state 1 (3.13%) 2 (5.41%) 0.553 0.009–11.116 1 b
IVDA History 1 (3.13%) 1 (2.70%) 1.098 0.014–88.88 1 b
Clinical characteristics
Time of symptom onset to presentation
Equal or less than 2 days 6 (18.75%) 16 (43.24%) 0.318 0.085–1.058 0.066 b
More than 2 days 24 (75.00%) 20 (54.05%)
Visual acuity at presentation
NLP 15 (46.88%) 2 (5.41%) 17.832 3.476–180.530 0.00003 b
LP 7 (21.88%) 12 (32.43%) 0.667 0.187–2.232 0.642 c
HM 4 (12.59%) 11 (29.73%) 0.383 0.0785–1.517 0.1497 b
CF or better 3 (9.38%) 12 (32.43%) 0.2453 0.0397–1.060 0.044 b
Final diagnosis of panophthalmitis or endophthalmitis
Panophthalmitis 12 (37.50%) 2 (5.41%) 10.15 1.967–102.461 0.002 b
Endophthalmitis 20 (62.50%) 35 (95.59%)
Culture Information
Positive culture 16 (50.00%) 15 (40.54%) 1.458 0.509–4.239 0.586 c
Bacteria 16 (50.00%) 14 (37.84%) 1.631 0.567–4.784 0.4396 c
Fungus 0 (0.00%) 1 (2.70%) 0 0.000–45.063 1 b
Gram+ 10 (31.25%) 12 (32.43%) 0.346 0.0273–2.701 0.3898 b
Gram− 5 (15.63%) 2 (5.41%)

OR: odds ratio; CI: confidence interval; IVDA: intravenous drug abuse, OD: right eye; OS: left eye; NLP: no light perception; LP: light perception; HM: hand motion; CF: counting fingers; EP: eye preserved. a Welch’s t-test. b Fisher’s exact test (for count data). c Pearson’s chi-square test.